Veralto Co. (NYSE:VLTO) is Quantbot Technologies LP's 6th Largest Position

Quantbot Technologies LP increased its position in shares of Veralto Co. (NYSE:VLTO - Free Report) by 77.1% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 149,756 shares of the company's stock after acquiring an additional 65,213 shares during the period. Veralto makes up about 0.7% of Quantbot Technologies LP's holdings, making the stock its 6th biggest position. Quantbot Technologies LP owned 0.06% of Veralto worth $16,752,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of VLTO. Swedbank AB bought a new position in shares of Veralto in the first quarter worth approximately $237,864,000. Principal Financial Group Inc. increased its holdings in shares of Veralto by 207.2% in the 3rd quarter. Principal Financial Group Inc. now owns 1,122,898 shares of the company's stock worth $125,608,000 after buying an additional 757,389 shares during the last quarter. Ferguson Wellman Capital Management Inc. purchased a new stake in shares of Veralto during the 2nd quarter valued at $39,343,000. Point72 Asset Management L.P. bought a new stake in shares of Veralto during the 2nd quarter worth $24,618,000. Finally, Bank of Montreal Can grew its position in Veralto by 106.0% in the third quarter. Bank of Montreal Can now owns 455,474 shares of the company's stock worth $50,239,000 after acquiring an additional 234,323 shares in the last quarter. 91.28% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on VLTO shares. BMO Capital Markets upped their price objective on Veralto from $117.00 to $119.00 and gave the stock an "outperform" rating in a report on Monday, September 30th. TD Cowen raised their target price on shares of Veralto from $95.00 to $100.00 and gave the stock a "hold" rating in a report on Tuesday, July 30th. UBS Group assumed coverage on shares of Veralto in a research report on Tuesday, August 13th. They set a "neutral" rating and a $118.00 price target for the company. The Goldman Sachs Group boosted their price objective on shares of Veralto from $104.00 to $116.00 and gave the company a "buy" rating in a research report on Monday, July 29th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on shares of Veralto from $100.00 to $109.00 and gave the stock a "hold" rating in a report on Monday, July 29th. Seven investment analysts have rated the stock with a hold rating and five have given a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Hold" and an average price target of $108.27.

Insider Activity at Veralto

In related news, SVP Surekha Trivedi sold 753 shares of the business's stock in a transaction that occurred on Tuesday, September 3rd. The shares were sold at an average price of $111.10, for a total transaction of $83,658.30. Following the completion of the sale, the senior vice president now directly owns 11,918 shares in the company, valued at approximately $1,324,089.80. The trade was a 5.94 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jennifer Honeycutt sold 13,191 shares of the firm's stock in a transaction on Friday, August 30th. The stock was sold at an average price of $111.98, for a total value of $1,477,128.18. Following the completion of the transaction, the chief executive officer now directly owns 138,546 shares in the company, valued at approximately $15,514,381.08. This represents a 8.69 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 28,639 shares of company stock valued at $3,175,803 over the last ninety days. Insiders own 0.31% of the company's stock.

Veralto Stock Down 0.5 %

Shares of Veralto stock traded down $0.52 during midday trading on Tuesday, hitting $107.96. The company had a trading volume of 1,369,044 shares, compared to its average volume of 1,541,347. The company has a 50 day moving average of $108.08 and a 200 day moving average of $104.59. The company has a debt-to-equity ratio of 1.35, a quick ratio of 1.87 and a current ratio of 2.13. The stock has a market capitalization of $26.70 billion and a P/E ratio of 33.48. Veralto Co. has a 52-week low of $72.85 and a 52-week high of $115.00.

Veralto (NYSE:VLTO - Get Free Report) last announced its quarterly earnings data on Wednesday, October 23rd. The company reported $0.89 EPS for the quarter, beating the consensus estimate of $0.85 by $0.04. Veralto had a net margin of 15.69% and a return on equity of 52.85%. The company had revenue of $1.31 billion for the quarter, compared to the consensus estimate of $1.30 billion. During the same period in the prior year, the firm posted $0.75 EPS. Veralto's revenue for the quarter was up 4.7% on a year-over-year basis. On average, equities analysts predict that Veralto Co. will post 3.48 earnings per share for the current fiscal year.

Veralto Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, October 31st. Stockholders of record on Friday, September 27th were issued a dividend of $0.09 per share. This represents a $0.36 dividend on an annualized basis and a dividend yield of 0.33%. The ex-dividend date was Friday, September 27th. Veralto's payout ratio is currently 11.11%.

Veralto Company Profile

Veralto Corporation provides water analytics, water treatment, marking and coding, and packaging and color services worldwide. It operates through two segments, Water Quality (WQ) and Product Quality & Innovation (PQI). The WQ segment offers precision instrumentation and water treatment technologies to measure, analyze, and treat water in residential, commercial, municipal, industrial, research, and natural resource applications through the Hach, Trojan Technologies, and ChemTreat brands.